1/22
Looks like no tags are added yet.
Cosyntropin MOA
synthetic formulation of ACTH
Cosyntropin primary indication
1) used to distinguish CAH from ovarian hyperandrogenism
2) used to diagnose adrenal insufficiency
Cosyntropin notable aspect
not used therapeutically, only for diagnostic purposes
Somatostatin MOA
inhibits secretion of growth hormones
Somatostatin primary indication
excess growth hormone
Somatostatin notable aspect
very short half-life of a few minutes
Octreotide MOA
inhibits secretion of growth hormones
inhibits insulin secretion
Octreotide primary indication
treatment of acromegaly
treatment of carcinoid tumors
Octreotide notable aspect
longer half-life than somatostatin
Leuprolide MOA
synthetic GnRH agonist
Leuprolide primary indication
continuous administration: initially increases LH/FSH before suppressing them through receptor downregulation
pulsatile administration - used to treat GnRH deficiency and mimic natural pulsatile secretion of GnRH
Leuprolide notable aspect
continuous administration can be used in the treatment of central precocious puberty
Cabergoline MOA
Dopamine agonist
since dopamine leads to suppression of prolactin, it can decrease prolactin levels
Cabergoline primary indication
Hyperprolactinemia (often from a prolactin-secreting pituitary adenoma)
Desmopressin MOA
long acting synthetic analog of vasopressin
acts on V2 receptors in kidneys to increase water reabsorption by causing insertion of aquaporin channels
Desmopressin primary indication
treatment of nocturnal enuresis
treatment of diabetes insipidus
can be used to control bleeding
Desmopressin notable aspect
use with caution in patients with coronary artery disease
Conivaptan MOA
dual vasopressin antagonist at V1 and V2 receptors
Conivaptan primary indication
treatment of euvolemic and hypervolemic hyponatremia
Tolvaptan MOA
selective Vasopressin antagonist at the V2 receptors
Tolvaptan primary indication
treatment of euvolemic and hypervolemic hyponatremia
treatment of SIADH (inappropriate anti-diuretic hormone)
Oxytocin MOA
synthetic oxytocin
Oxytocin primary indication
induces and enhances uterine contractions in labor
prevention and treatment of postpartum hemorrhage